Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 2.41 | 8.13 |
| PEG Ratio (TTM) | -0.16 | 0.27 |
| P/S Ratio (TTM) | 0.08 | 2.84 |
| P/B Ratio (TTM) | 0.16 | 1.61 |
| P/FCF Ratio (TTM) | 0.11 | 39.22 |
| Price to 5YR AVG Earnings Ratio | 2.61 | 15.84 |
| Price to 5YR AVG FCF Ratio | 0.58 | 32.96 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.61% | 8.04% |
| ROE (TTM) | 7.43% | 17.09% |
| Net Profit Margin (TTM) | 3.35% | 30.29% |
| ROIC 5YR AVG | 37.63% | 6.51% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.46% | 4.15% | 14.25% |
| Revenue | 3.86% | 9.07% | 7.82% |
| Net Income | -9.02% | 5.97% | 15.23% |
| Cash Flow | 252.71% | 38.60% | 49.81% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 23.71 |
| Quick Ratio (TTM) | N/A | 22.52 |
| D/E Ratio (TTM) | 0.46 | 0.22 |
| Interest Coverage (TTM) | 16.61 | 10.35 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.16 | 2.63 |
| LTL to 5YR AVG FCF | 1.47 | 4.56 |
| Shares Outstanding Growth 5YR AVG | 1.09% | -2.58% |